Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-28 @ 11:57 PM
Study NCT ID:
NCT07059650
Status:
RECRUITING
Last Update Posted:
2025-08-28
First Post:
2025-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
Sponsor:
Dizal Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2030-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-16
First Submit QC Date:
None
Study First Post Date:
2025-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-22
Last Update Post Date:
2025-08-28
Last Update Post Date Type:
ESTIMATED